https://actionforat.org/wp-content/uploads/2024/10/Dr-Ramsay-Bowden.jpg
658
502
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-10-14 16:19:322024-10-15 11:59:41Improving diagnosis and treatment of cancer in Ataxia-Telangiectasia patients through whole genome sequencing
https://actionforat.org/wp-content/uploads/2024/09/2023_03_13-Samuel-M-Young-Jr.-klaird-005-PIC-scaled.jpg
2560
2048
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-09-17 13:24:182024-09-17 13:24:18Development of a Gene Therapy approach to treat A-T
https://actionforat.org/wp-content/uploads/2020/07/Robert-Dineen.jpg
1186
1246
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-09-16 10:54:582024-10-09 14:39:23Biomarkers for Babies and Young Children with Ataxia Telangiectasia (BOBCAT)
https://actionforat.org/wp-content/uploads/2024/09/Richard-Tuxworth-0620-scaled.jpg
2560
1920
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-09-16 10:09:372024-10-09 14:55:20Identifying existing drugs to repurpose for treating Ataxia-Telangiectasia
https://actionforat.org/wp-content/uploads/2024/09/PaolaGiunti.jpg
606
756
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-09-16 09:00:462024-09-16 12:25:23Exploring Omaveloxolone efficacy in Ataxia-telangiectasia
https://actionforat.org/wp-content/uploads/2024/08/Mirjam-van-der-Burg-pic-scaled-e1724068718352.jpg
1920
1706
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-08-19 12:57:062024-09-16 10:42:13Functional impact of Nicotinamide Riboside on the immune system of patients with A-T
https://actionforat.org/wp-content/uploads/2023/06/Caroline-Blanchard.jpg
1021
1006
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-07-16 11:45:472024-07-16 17:16:23STIM A-T Pilot Study
https://actionforat.org/wp-content/uploads/2023/06/Professor-Philip-Breedon-e1686322856820.png
324
422
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-07-11 10:33:152024-07-11 11:54:20Virtual Reality in Ataxia-Telangiectasia
https://actionforat.org/wp-content/uploads/2024/06/Picture-Zoya-Ignatova.jpg
1080
1600
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-06-14 15:37:432024-08-21 14:28:56Development of suppressor tRNA-based therapeutics
https://actionforat.org/wp-content/uploads/2019/11/Molina-2019-e1573232697281.jpg
208
227
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-06-04 16:02:282024-06-04 16:28:16Innovative methods for gene therapy in Ataxia-Telangiectasia
https://actionforat.org/wp-content/uploads/2020/06/Professor-Margot-Mayer-Proschel-e1610453240421.jpg
267
320
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-06-04 10:19:562024-06-04 16:24:11Recurrent pulmonary infections and their impact on neurological decline in A-T
https://actionforat.org/wp-content/uploads/2020/07/Robert-Dineen.jpg
1186
1246
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-02-25 13:30:582024-08-14 15:21:17The David Peake Study to test the feasibility of whole-body MRI for cancer surveillance in children and young people with Ataxia Telangiectasia
https://actionforat.org/wp-content/uploads/2020/07/GStewart-profile-picture.jpg
942
678
Neale Sterio
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Neale Sterio2024-01-31 11:07:282024-07-16 17:18:22Deciphering the molecular mechanism linking A-T and A-T-Like Disorder
https://actionforat.org/wp-content/uploads/2024/01/Hilde-Loge-Nilsen-Oslo-University-Hospital-Norway-scaled-e1706089004538.jpg
381
400
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-01-24 09:39:312024-02-21 12:55:57Preclinical Assessment of Intrathecal rAAV9-Mediated miATM Therapy for Ataxia Telangiectasia in Mouse Models.
https://actionforat.org/wp-content/uploads/2024/01/Nuria-Montserrat-IBEC-Barcelona-Spain-cropped-e1706088205179.jpg
468
400
Sean Kelly
https://actionforat.org/wp-content/uploads/2016/01/action-for-at-logo.png
Sean Kelly2024-01-24 09:29:372024-01-24 10:35:15Modelling Ataxia Telangiectasia pathogenesis and therapeutics using human pluripotent stem cells and genetic engineering.
